Literature DB >> 20348094

Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins.

John E Hall1, Alexandre A da Silva, Jussara M do Carmo, John Dubinion, Shereen Hamza, Shankar Munusamy, Grant Smith, David E Stec.   

Abstract

Excess weight gain contributes to increased blood pressure in most patients with essential hypertension. Although the mechanisms of obesity hypertension are not fully understood, increased renal sodium reabsorption and impaired pressure natriuresis play key roles. Several mechanisms contribute to altered kidney function and hypertension in obesity, including activation of the sympathetic nervous system, which appears to be mediated in part by increased levels of the adipocyte-derived hormone leptin, stimulation of pro-opiomelanocortin neurons, and subsequent activation of central nervous system melanocortin 4 receptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20348094      PMCID: PMC2878489          DOI: 10.1074/jbc.R110.113175

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin.

Authors:  Lakshmi S Tallam; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2006-06-05       Impact factor: 10.190

Review 2.  Mechanisms of sympathetic activation in obesity-related hypertension.

Authors:  Murray Esler; Nora Straznicky; Nina Eikelis; Kazuko Masuo; Gavin Lambert; Elisabeth Lambert
Journal:  Hypertension       Date:  2006-09-25       Impact factor: 10.190

3.  Crossing the border: developmental regulation of leptin transport to the brain.

Authors:  Sebastien G Bouret
Journal:  Endocrinology       Date:  2008-03       Impact factor: 4.736

Review 4.  Leptin signaling and obesity: cardiovascular consequences.

Authors:  Ronghua Yang; Lili A Barouch
Journal:  Circ Res       Date:  2007-09-14       Impact factor: 17.367

Review 5.  The role of the sympathetic nervous system in obesity-related hypertension.

Authors:  Alexandre A da Silva; Jussara do Carmo; John Dubinion; John E Hall
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

6.  Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Bela Kanyicska; John Dubinion; Elizabeth Brandon; John E Hall
Journal:  Hypertension       Date:  2008-02-19       Impact factor: 10.190

7.  Prevalence of obesity among US preschool children in different racial and ethnic groups.

Authors:  Sarah E Anderson; Robert C Whitaker
Journal:  Arch Pediatr Adolesc Med       Date:  2009-04

Review 8.  Recent advances in understanding leptin signaling and leptin resistance.

Authors:  David L Morris; Liangyou Rui
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-09-01       Impact factor: 4.310

9.  Modulation of blood pressure by central melanocortinergic pathways.

Authors:  Jerry R Greenfield; Jeffrey W Miller; Julia M Keogh; Elana Henning; Julie H Satterwhite; Gregory S Cameron; Beatrice Astruc; John P Mayer; Soren Brage; Teik Choon See; David J Lomas; Stephen O'Rahilly; I Sadaf Farooqi
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

Review 10.  Science of self-preservation: how melanocortin action in the brain modulates body weight, blood pressure, and ischemic damage.

Authors:  Marcus P Corander; Matthew Fenech; Anthony P Coll
Journal:  Circulation       Date:  2009-12-01       Impact factor: 29.690

View more
  197 in total

1.  Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of oestrogen.

Authors:  Zhigang Shi; Virginia L Brooks
Journal:  J Physiol       Date:  2014-12-22       Impact factor: 5.182

2.  Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats.

Authors:  Jussara M do Carmo; Alexandre A da Silva; John S Rushing; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-28       Impact factor: 3.619

3.  Adipocyte dysfunction and hypertension.

Authors:  Junlan Zhou; Gangjian Qin
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

4.  Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.

Authors:  Hiroyuki Kobori; Qi Fu; Steven D Crowley; Romer A Gonzalez-Villalobos; Ruy R Campos
Journal:  J Appl Physiol (1985)       Date:  2010-12

Review 5.  Sodium-retaining effect of insulin in diabetes.

Authors:  Michael W Brands; M Marlina Manhiani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-03       Impact factor: 3.619

6.  Leptin into the ventrolateral medulla facilitates chemorespiratory response in leptin-deficient (ob/ob) mice.

Authors:  M Bassi; W I Furuya; J V Menani; D S A Colombari; J M do Carmo; A A da Silva; J E Hall; T S Moreira; I C Wenker; D K Mulkey; E Colombari
Journal:  Acta Physiol (Oxf)       Date:  2014-03-13       Impact factor: 6.311

7.  High-fat food, sympathetic nerve activity, and hypertension: danger soon after the first bite?

Authors:  Virginia L Brooks; John W Osborn
Journal:  Hypertension       Date:  2012-10-22       Impact factor: 10.190

Review 8.  Neural Control of Non-vasomotor Organs in Hypertension.

Authors:  Chansol Hurr; Colin N Young
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

Review 9.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

10.  Chronic hyperleptinemia results in the development of hypertension in pregnant rats.

Authors:  Ana C Palei; Frank T Spradley; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-11       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.